SERAPHIM SPACE INVESTMENT TRUST PLC
(the "Company")
Notice of Results
Seraphim Space Investment Trust plc (LSE: SSIT), the world's first listed SpaceTech investment company, will announce its interim results for the period ended 31 December 2023 on Wednesday 13th March 2024.
There will be a webinar for equity analysts at 09.30 (UK time) on the day of results. To register for the event, please contact SEC Newgate by email at seraphim@secnewgate.co.uk.
A further presentation for retail investors will be provided at 11.00 (UK time) on the same day. Investors can register for the event by emailing seraphim@secnewgate.co.uk.
Both presentations will be hosted by the Chair Will Whitehorn and Seraphim Space Manager LLP's CEO Mark Boggett and CIO James Bruegger.
- Ends -
Media Enquiries
Seraphim Space Manager LLP | Via SEC Newgate |
SEC Newgate (Communications advisers) | seraphim@secnewgate.co.uk |
Deutsche Numis | +44 (0) 20 7545 8000 |
J.P. Morgan Cazenove | +44 (0) 20 7742 4000 |
Ocorian Administration (UK) Limited | seraphimteam@ocorian.com |
Notes to Editors
About Seraphim Space Investment Trust plc
Seraphim Space Investment Trust plc ("SSIT" or the "Company") is the world's first listed fund focused on SpaceTech. The Company seeks exposure predominantly to early and growth stage private financed SpaceTech businesses that have the potential to dominate globally and that are sector leaders with first mover advantages in areas such as climate, communications, mobility and cyber security.
The Company is listed on the Premium Segment of the London Stock Exchange.
Further information is available at: https://investors.seraphim.vc.
About Seraphim Space Manager LLP
Seraphim Space Manager LLP ("Seraphim Space" or the "Manager") is based in the UK and manages Seraphim Space Investment Trust plc.
Further information is available at www.seraphim.vc.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.